The global femtech market is set to witness substantial growth, projected to reach USD 27,956.4 million in 2024, with a compound annual growth rate (CAGR) of 4.5% from 2024 to 2034. By the end of the forecast period, the market value is expected to rise to USD 43,406.1 million, highlighting the increasing importance of technology in addressing women’s health needs.
A significant driver of this market growth is the rising number of women entering the technology field. As primary users of femtech, women are demonstrating a strong preference for innovative solutions that cater specifically to their health concerns. The growing population of working professionals is further intensifying the demand for wearable and convenient health devices.
Moreover, the ongoing conversation around women’s health topics—previously shrouded in stigma—has transformed the landscape of femtech. Discussions surrounding menstrual health, menopause, and other critical issues are now more open, encouraging women to seek assistance for their health concerns without hesitation. Additionally, the rising incidence of sexually transmitted infections (STIs) and sexually transmitted diseases (STDs) among women is underscoring the necessity for femtech solutions that promote proactive health management.
Despite these promising trends, the femtech market faces notable challenges. The sensitive nature of the data involved in women’s health technology poses a significant concern. Many potential users remain wary of engaging with femtech due to fears of data breaches and privacy violations. Furthermore, reaching rural and underdeveloped areas presents obstacles, where stigmas surrounding women’s health still persist and technological infrastructure requires enhancement.
As the femtech market evolves, addressing these challenges will be crucial to ensuring that all women can benefit from the advancements in health technology. Stakeholders are encouraged to prioritize user privacy, expand accessibility, and foster education around women’s health to support the continued growth of this vital sector.
“Femtech is using technology to expand the scope of the market. Emerging general technologies like AI and voice assistants, as well as market-related technologies like electric breast pumps, are ensuring femtech products stay at the forefront of technology. Thus, technological advancement represents significant growth potential in the market,” says an analyst at FMI.
Key Takeaways from the Femtech Market:
- The femtech market is anticipated to be valued at US$ 27,956.4 million in 2024.
- Consumer products are the leading products in the market. For 2024, consumer products are expected to contribute to 19.9% of the market share.
- Menstrual health is the predominant concern for users of femtech. For 2024, menstrual health is anticipated to account for 18.0% of the market share by application.
- India is marked to be one of the leading countries in the market. During the 2024 to 2034 period, the CAGR for India is pegged to be 6.7%.
- Besides India, China is another promising Asian country for the market. For the forecast period, the market is expected to progress at a CAGR of 5.8% in China.
- The market is anticipated to progress at a CAGR of 2.9% in the United Kingdom.
Rising Demand for Market Data: Our Full Report Offers Deep Insights and Trend Analysis!
Competition Analysis of the Femtech Market:
The femtech market is competitive, with large-scale companies tussling with smaller counterparts for market dominance. Acquisitions, mergers, collaborations, and investment hunting are common in the market. Some prominent companies in the market are Flo Health, Inc., Natural Cycles USA Corp., Glow, Inc., and Clue by Biowink GmbH.
Recent Developments in the Femtech Market:
- In November 2023, Bayer and CrossBay Medical announced a collaboration to develop a pain-reducing intrauterine system inserter.
- In November 2023, the MyBreastAi suite was launched by GE, combining AI capabilities with mammography.
- In October 2023, MEDICE Health Family entered the market by acquiring Femfeel.
Key Companies in the Femtech Market:
- Flo Health Inc.
- Apple Inc.
- Clue by Biowink GmbH
- Glow Inc.
- Google Inc.
- Natural Cycles USA Corp
- Withings
- Fitbit Inc.
Key Segments:
By Product Type:
- Diagnostics
- Monitoring
- Therapeutic
- Consumer Products
By Application:
- General Health and Wellness
- Maternity Care
- Menstrual Health
- Pelvic and Uterine Healthcare
- Cancer and Chronic Disease
By End User:
- Direct-to-consumer
- Hospitals
- Surgical Centers
- Fertility Clinics
- Diagnostics Centers
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube